According to Bloomberg News, Vinay Prasad, who oversees gene therapies at the FDA, said the plans will be published in early November. He foresees the approach sparking curiosity for the next wave of ...

A new medication for treatment-resistant depression may help a subset of people who carry a specific genetic marker.

In a world first, a bespoke gene-editing therapy benefitted one child. Now reseachers plan to launch a clinical trial of the ...

New methods of testing tissue and plasma beyond next-generation sequencing (NGS) could be used to deliver the best ...

DNA shines a light back into the past, showing us things that fossils can't. But how far back can that light extend? Some of the oldest DNA sequences come from mastodon and polar bear fossils about 50 ...

An artificial intelligence model predicts how brain immune cells react to RNA and DNA nanoparticles, helping scientists design safer and more effective nucleic acid therapies faster.

Clonal hematopoiesis of indeterminate potential (CHIP) is a known risk factor for coronary artery disease, though its precise role in disease progression continues to emerge. This study leverages ...

Standard laboratory tests can fail to detect many disease-causing DNA changes. Now, a novel 3D chromosome mapping method can ...

Oats are having a moment. As a highly nutritious cereal crop with well-documented health benefits, it's no surprise oat-based ...

Swiss Rockets, MGI US LLC and Complete Genomics Inc. announced today that they entered into a exclusive license agreement ...

New scientific article warns of loss of consumer trust unless proper analysis is done. Report: Claire Robinson ...